Lipoprotein(a) levels predict adverse vascular events after acute myocardial infarction-Reference-Cited by-同舟云学术

Lipoprotein(a) levels predict adverse vascular events after acute myocardial infarction

Published:2016-03-02 Issue:12 Volume:31 Page:1923-1929
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Mitsuda Takayuki,Uemura Yusuke,Ishii Hideki,Takemoto Kenji,Uchikawa Tomohiro,Koyasu Masayoshi,Ishikawa Shinji,Miura Ayako,Imai Ryo,Iwamiya Satoshi,Ozaki Yuta,Kato Tomohiro,Shibata Rei,Watarai Masato,Murohara Toyoaki

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-016-0823-0.pdf

Reference35 articles.

1. Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini H, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, Ulm K (1996) A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334:1084–1089

2. Sakurai K, Watanabe J, Iwabuchi K, Koseki Y, Kon-no Y, Fukuchi M, Komura T, Shinozaki T, Miura M, Sakuma M, Kagaya Y, Kitaoka S, Shirato K (2003) Comparison of the efficacy of reperfusion therapies for early mortality from acute myocardial infarction in Japan: registry of Miyagi Study Group for AMI (MsAMI). Circ J 67:209–214

3. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, Skidmore B, Stone JA, Thompson DR, Oldridge N (2004) Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 116:682–692

4. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T (2001) Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285:1711–1718

5. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350:1495–1504

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of elevated lipoprotein (a) in patients with acute coronary syndromes: a systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2024-05-09

2. Baseline Lipoprotein(a) Levels and Long-Term Cardiovascular Outcomes After Acute Myocardial Infarction;Journal of Korean Medical Science;2023

3. Lipoprotein (a): A Potential New Target for Acute ST-Segment Elevation Myocardial Infarction;Advances in Clinical Medicine;2023

4. Effect of the Early Application of Evolocumab on Blood Lipid Profile and Cardiovascular Prognosis in Patients with Extremely High-Risk Acute Coronary Syndrome;International Heart Journal;2022-07-30

5. Relationship between lipoprotein(a) and revascularization after percutaneous coronary intervention in type 2 diabetes mellitus patients with acute coronary syndrome;Current Medical Research and Opinion;2022-05-26